Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 5312813, 6 pages
https://doi.org/10.1155/2017/5312813
Review Article

Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms

1Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia Medical School, Foggia, Italy
2Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy
3National Cancer Institute “Giovanni Paolo II”, Bari, Italy

Correspondence should be addressed to Francesco Paolo Cantatore

Received 1 April 2017; Revised 5 June 2017; Accepted 13 June 2017; Published 19 July 2017

Academic Editor: Ruben Queiro-Silva

Copyright © 2017 Francesco Paolo Cantatore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. I. Sakkas, I. Alexiou, T. Simopoulou, and M. Vlychou, “Enthesitis in psoriatic arthritis,” Seminars in Arthritis and Rheumatism, vol. 43, no. 3, pp. 325–334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Rajesh, D. O. Kataria, and L. H. Brent, “Spondyloarthropathies,” American Family Physician, vol. 69, pp. 2853–2860, 2004. View at Google Scholar · View at Scopus
  3. T. Yamamoto, “Psoriatic arthritis: from a dermatological perspective,” European Journal of Dermatology, vol. 21, no. 5, pp. 660–666, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. G. van de Sande and D. L. Baeten, “Immunopathology of synovitis: from histology to molecular pathways,” Rheumatology, vol. 55, no. 4, pp. 599–606, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Risau, “Mechanisms of angiogenesis,” Nature, vol. 386, no. 6626, pp. 671–674, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. S. Pepper, “Manipulating angiogenesis: from basic science to the bedside,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 4, pp. 605–619, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. K. M. Dameron, O. V. Volpert, M. A. Tainsky, and N. Bouck, “Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1,” Science, vol. 265, no. 5178, pp. 1582–1584, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. O’Reilly, L. Holmgren, Y. Shing et al., “Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma,” Cell, vol. 79, no. 2, pp. 315–328, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. M. S. O’Reilly, T. Boehm, Y. Shing et al., “Endostatin: an endogenous inhibitor of angiogenesis and tumor growth,” Cell, vol. 88, no. 2, pp. 277–285, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Maruotti, F. P. Cantatore, E. Crivellato, A. Vacca, and D. Ribatti, “Angiogenesis in rheumatoid arthritis,” Histology and Histopathology, vol. 21, no. 4–6, pp. 557–566, 2006. View at Google Scholar · View at Scopus
  11. N. Maruotti, F. P. Cantatore, B. Nico, A. Vacca, and D. Ribatti, “Angiogenesis in vasculitides,” Clinical and Experimental Rheumatology, vol. 26, no. 3, pp. 476–483, 2008. View at Google Scholar · View at Scopus
  12. M. Bhushan, T. Moore, A. L. Herrick, and C. E. M. Griffiths, “Nailfold video capillaroscopy in psoriasis,” British Journal of Dermatology, vol. 142, no. 6, pp. 1171–1176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Veale, G. Yanni, S. Rogers, L. Barnes, B. Bresnihan, and O. Fitzgerald, “Reduced synovial membrane macrophage numbers, elam-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis,” Arthritis & Rheumatism, vol. 36, no. 7, pp. 893–900, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Reece, J. D. Canete, W. J. Parsons, P. Emery, and D. J. Veale, “Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis,” Arthritis and Rheumatism, vol. 42, no. 7, pp. 1481–1484, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Veale, C. Ritchlin, and O. FitzGerald, “Immunopathology of psoriasis and psoriatic arthritis,” Annals of the Rheumatic Diseases, vol. 64, supplement 2, pp. 26–29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. H. A. Elshabrawy, Z. Chen, M. V. Volin, S. Ravella, S. Virupannavar, and S. Shahrara, “The pathogenic role of angiogenesis in rheumatoid arthritis,” Angiogenesis, vol. 18, no. 4, pp. 433–448, 2015. View at Publisher · View at Google Scholar
  17. K. H. Falchuk, E. J. Goetzl, and J. P. Kulka, “Respiratory gases of synovial fluids: an approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis,” The American Journal of Medicine, vol. 49, no. 2, pp. 223–231, 1970. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Lund-Olesen, “Oxygen tension in synovial fluids,” Arthritis and Rheumatism, vol. 13, no. 6, pp. 769–776, 1970. View at Publisher · View at Google Scholar · View at Scopus
  19. C. M. Quiñonez-Flores, S. A. González-Chávez, and C. Pacheco-Tena, “Hypoxia and its implications in rheumatoid arthritis,” Journal of Biomedical Science, vol. 23, no. 1, article 62, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. C. T. Ng, M. Biniecka, A. Kennedy et al., “Synovial tissue hypoxia and inflammation in vivo,” Annals of the Rheumatic Diseases, vol. 69, no. 7, pp. 1389–1395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Sivakumar, M. A. Akhavani, C. P. Winlove, P. C. Taylor, E. M. Paleolog, and N. Kang, “Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis,” Journal of Hand Surgery, vol. 33, no. 1, pp. 49–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Akhavani, L. Madden, I. Buysschaert, B. Sivakumar, N. Kang, and E. M. Paleolog, “Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 11, no. 3, article R64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Muz, M. N. Khan, S. Kiriakidis, and E. M. Paleolog, “Hypoxia: the role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 11, article 201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Konisti, S. Kiriakidis, and E. M. Paleolog, “Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 8, no. 3, pp. 153–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Marrelli, P. Cipriani, V. Liakouli et al., “Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?” Autoimmunity Reviews, vol. 10, no. 10, pp. 595–598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. P. Hollander, K. P. Corke, A. J. Freemont, and C. E. Lewis, “Expression of hypoxia-inducible factor 1α by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint,” Arthritis and Rheumatism, vol. 44, no. 7, pp. 1540–1544, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Tischer, R. Mitchell, T. Hartman et al., “The Human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing,” Journal of Biological Chemistry, vol. 266, no. 18, pp. 11946–11954, 1991. View at Google Scholar · View at Scopus
  28. A. Palazon, A. Goldrath, V. Nizet, and R. Johnson, “HIF transcription factors, inflammation, and immunity,” Immunity, vol. 41, no. 4, pp. 518–528, 2014. View at Publisher · View at Google Scholar
  29. K. M. Oliver, C. T. Taylor, and E. P. Cummins, “Hypoxia. Regulation of NFκB signalling during inflammation: the role of hydroxylases,” Arthritis Research & Therapy, vol. 11, article 215, 2009. View at Publisher · View at Google Scholar
  30. M. Valko, M. Izakovic, M. Mazur, C. J. Rhodes, and J. Telser, “Role of oxygen radicals in DNA damage and cancer incidence,” Molecular and Cellular Biochemistry, vol. 266, no. 1-2, pp. 37–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Ray and A. M. Shah, “NADPH oxidase and endothelial cell function,” Clinical Science, vol. 109, no. 3, pp. 217–226, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. R. S. Frey, M. Ushio-Fukai, and A. B. Malik, “NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology,” Antioxidants & Redox Signaling, vol. 11, no. 4, pp. 791–810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Manea, “NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology,” Cell and Tissue Research, vol. 342, no. 3, pp. 325–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Biniecka, M. Connolly, W. Gao et al., “Redox-mediated angiogenesis in the hypoxic joint of inflammatory arthritis,” Arthritis and Rheumatology, vol. 66, no. 12, pp. 3300–3310, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Garcia-Carbonell, A. S. Divakaruni, A. Lodi et al., “Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes,” Arthritis and Rheumatology, vol. 68, no. 7, pp. 1614–1626, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Biniecka, M. Canavan, T. McGarry et al., “Dysregulated bioenergetics: a key regulator of joint inflammation,” Annals of the Rheumatic Diseases, vol. 75, no. 12, pp. 2192–2200, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Creamer, R. Jaggar, M. Allen, R. Bicknell, and J. Barker, “Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis,” British Journal of Dermatology, vol. 137, no. 6, pp. 851–855, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Kuroda, A. Sapadin, T. Shoji, R. Fleischmajer, and M. Lebwohl, “Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis,” Journal of Investigative Dermatology, vol. 116, no. 5, pp. 713–720, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. U. Fearon, R. Reece, J. Smith, P. Emery, and D. J. Veale, “Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients,” Annals of the New York Academy of Sciences, vol. 878, pp. 619–621, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. U. Fearon, K. Griosios, A. Fraser et al., “Angiopoietins, growth factors, and vascular morphology in early arthritis,” The Journal of Rheumatology, vol. 30, no. 2, pp. 260–268, 2003. View at Google Scholar · View at Scopus
  41. D. Kane, L. E. Jensen, S. Grehan, A. S. Whitehead, B. Bresnihan, and O. Fitzgerald, “Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction,” The Journal of Rheumatology, vol. 31, no. 7, pp. 1274–1280, 2004. View at Google Scholar · View at Scopus
  42. A. Fraser, U. Fearon, R. Reece, P. Emery, and D. J. Veale, “Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis,” Arthritis and Rheumatism, vol. 44, no. 9, pp. 2024–2028, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Kruithof, D. Baeten, L. De Rycke et al., “Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis,” Arthritis Research & Therapy, vol. 7, no. 3, pp. R569–580, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. W. Gao, C. Sweeney, C. Walsh et al., “Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2,” Annals of the Rheumatic Diseases, vol. 72, no. 6, pp. 1080–1088, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Kennedy, C. T. Ng, M. Biniecka et al., “Angiogenesis and blood vessel stability in inflammatory arthritis,” Arthritis and Rheumatism, vol. 62, no. 3, pp. 711–721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Yamamoto, “Angiogenic and inflammatory properties of psoriatic arthritis,” ISRN Dermatology, vol. 2013, Article ID 630620, 7 pages, 2013. View at Publisher · View at Google Scholar
  47. S. Ballara, P. C. Taylor, P. Reusch et al., “Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis,” Arthritis and Rheumatism, vol. 44, no. 9, pp. 2055–2064, 2001. View at Google Scholar · View at Scopus
  48. S. C. Ballara, J. M. Miotla, and E. M. Paleolog, “New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders,” International Journal of Experimental Pathology, vol. 80, no. 5, pp. 235–250, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. D. A. Walsh, “Angiogenesis and arthritis,” Rheumatology, vol. 38, no. 2, pp. 103–112, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Przepiera-Będzak, K. Fischer, and M. Brzosko, “Serum levels of angiogenic cytokines in psoriatic arthritis and SAPHO syndrome,” Polish Archives of Internal Medicine, vol. 123, no. 6, pp. 297–302, 2013. View at Publisher · View at Google Scholar
  51. H. S. Young, A. M. Summers, M. Bhushan, P. E. C. Brenchley, and C. E. M. Griffiths, “Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset,” The Journal of Investigative Dermatology, vol. 122, no. 1, pp. 209–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Barile, E. Medda, L. Nisticò et al., “Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis,” Experimental Dermatology, vol. 15, no. 5, pp. 368–376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Butt, S. Lim, C. Greenwood, and P. Rahman, “VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis,” BMC Musculoskeletal Disorders, vol. 8, article 1, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S. W. Han, G. W. Kim, J. S. Seo et al., “VEGF gene polymorphisms and susceptibility to rheumatoid arthritis,” Rheumatology, vol. 43, no. 9, pp. 1173–1177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Seibl, T. Birchler, S. Loeliger et al., “Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium,” American Journal of Pathology, vol. 162, no. 4, pp. 1221–1227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. S.-H. Kok, C.-Y. Hong, M. Y.-P. Kuo et al., “Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: an implication for the pathogenesis of arthritis,” Arthritis and Rheumatism, vol. 60, no. 5, pp. 1451–1462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. U. Fearon, R. Mullan, T. Markham et al., “Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures,” Arthritis and Rheumatism, vol. 54, no. 10, pp. 3152–3162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Son, S. H. Lee, S. Lee et al., “Oncostatin M suppresses activation of IL-17/Th17 via SOCS3 regulation in CD4,” The Journal of Immunology, vol. 198, no. 4, pp. 1484–1491, 2017. View at Publisher · View at Google Scholar
  59. A. Mastroianni, E. Minutilli, A. Mussi et al., “Cytokine profiles during infliximab monotherapy in psoriatic arthritis,” British Journal of Dermatology, vol. 153, no. 3, pp. 531–536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Cordiali-Fei, E. Trento, G. D'Agosto et al., “Effective therapy with anti-TNF-α in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions,” Annals of the New York Academy of Sciences, vol. 1110, pp. 578–589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. J. D. Cañete, J. L. Pablos, R. Sanmartí et al., “Antiangiogenic effects of anti-tumor necrosis factor α therapy with infliximab in psoriatic arthritis,” Arthritis and Rheumatism, vol. 50, no. 5, pp. 1636–1641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Y. Goedkoop, M. C. Kraan, D. I. Picavet et al., “Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study,” Arthritis Research & Therapy, vol. 6, no. 4, pp. R326–334, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Moss, “The angiopoietin: TIe 2 interaction: a potential target for future therapies in human vascular disease,” Cytokine and Growth Factor Reviews, vol. 24, no. 6, pp. 579–592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Tanaka, M. Mori, Y. Sakamoto, M. Makuuchi, K. Sugimachi, and J. R. Wands, “Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma,” Journal of Clinical Investigation, vol. 103, no. 3, pp. 341–345, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. I. B. Lobov, P. C. Brooks, and R. A. Lang, “Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 17, pp. 11205–11210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. S. García, S. Krausz, C. A. Ambarus et al., “Tie2 signaling cooperates with TNF to promote the pro-inflammatory activation of human macrophages independently of macrophage functional phenotype,” PLoS ONE, vol. 9, no. 1, Article ID e82088, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Cordiali-Fei, E. Trento, G. D'Agosto et al., “Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-α,” Journal of Autoimmune Diseases, vol. 3, article 5, 2006. View at Publisher · View at Google Scholar · View at Scopus